article · Inflammopharmacology
L-carnitine supplementation may offer cardioprotective benefits in CAD patients; however, given the inconsistent results regarding certain clinical endpoints, further large-scale, long-term randomized trials are required.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s10787-025-02048-7
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
